Search results - 2 results
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
lower response to the vaccine such as anti- CD19, anti- CD20 or anti- CD38 therapies, low (naive) CD4 T-cell counts, genetic or therapeutic Bruton tyrosine kinase deficiency, treatment with ...
Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.
Françoise Benoit-Vical; Pierrette Melin; Patrick De Mol; Marie-Pierre Hayette Source: PLoS One, Volume 12, Issue 6 (2017) Keywords: Artemisinins Democratic Republic of the Congo Drug Resistance Drug Therapy ...